All cancer types, Lymphoma
Results
Phase 1/2
This trial looked at a drug called CXD101 to treat cancer. It was for people who had a or that had:
got worse despite treatment and
there wasn’t a available
This trial was open for people to join between 2018 and 2019. The team published the results in 2021.
Recruitment start: 1 March 2014
Recruitment end: 9 September 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mark Middleton
Celleron Therapeutics Ltd
Experimental Cancer Medicine Centre (ECMC)
Oxford University Hospitals NHS Trust
Last reviewed: 07 Aug 2022
CRUK internal database number: 6423
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
